1. Home
  2. CDNA vs INMD Comparison

CDNA vs INMD Comparison

Compare CDNA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$20.42

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.91

Market Cap

879.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
INMD
Founded
1998
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
879.2M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
CDNA
INMD
Price
$20.42
$13.91
Analyst Decision
Buy
Hold
Analyst Count
7
6
Target Price
$26.67
$16.75
AVG Volume (30 Days)
723.7K
698.9K
Earning Date
02-25-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
1.22
2.21
Revenue
$357,998,000.00
$364,494,000.00
Revenue This Year
$14.47
N/A
Revenue Next Year
$11.35
$3.33
P/E Ratio
$16.81
$6.31
Revenue Growth
14.46
N/A
52 Week Low
$10.96
$13.14
52 Week High
$25.55
$19.78

Technical Indicators

Market Signals
Indicator
CDNA
INMD
Relative Strength Index (RSI) 56.46 41.10
Support Level $19.48 $13.73
Resistance Level $21.49 $14.23
Average True Range (ATR) 1.18 0.42
MACD 0.09 -0.08
Stochastic Oscillator 76.57 9.27

Price Performance

Historical Comparison
CDNA
INMD

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Share on Social Networks: